Cargando…
Regenerative medicine meets translational oncology: Modeling leukemic bone marrow niche
Most studies on leukemia focus on leukemia cells as isolated objects without considering the bone marrow niche. Pal et al. have recreated the bone marrow niche using induced pluripotent stem cells (iPSCs), identifying CDH2 as a therapeutically druggable leukemia-promoting factor.(1)
Autores principales: | Borbaran-Bravo, Natalia, Arreba-Tutusaus, Patricia, Ritter, Malte U., Nasri, Masoud, Klimiankou, Maksim, Skokowa, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418842/ https://www.ncbi.nlm.nih.gov/pubmed/35977470 http://dx.doi.org/10.1016/j.xcrm.2022.100724 |
Ejemplares similares
-
P751: UNRAVELING THE DIFFERENT PATHOMECHANISMS OF CONGENITAL AND CYCLIC NEUTROPENIAS: CYCLIC EXPRESSION OF HEMATOPOIETIC STEM-CELL-SPECIFIC TRANSCRIPTION FACTORS IN CYCLIC NEUTROPENIA
por: Alexander Zeidler, Karl, et al.
Publicado: (2023) -
P1357: MILESTONE (MODIFYING ELANE GOLDBERG–HOGNES BOX TO INHIBIT EXPRESSION), A UNIVERSAL, SAFE AND EFFECTIVE CRISPR/CAS9N-MEDIATED GENOME EDITING STRATEGY FOR ELANE RELATED SEVERE CONGENITAL NEUTROPENIA
por: Nasri, Masoud, et al.
Publicado: (2023) -
Regenerative Medicine: Taming the Chimaera
por: Roelen, Bernard A.J.
Publicado: (2018) -
Stem Cells Translational Medicine
por: Atkinson, Stuart P.
Publicado: (2018) -
Black Lives Matter Worldwide: Retooling Precision Oncology for True Equity of Cancer Care
por: Rajagopal, Padma Sheila, et al.
Publicado: (2020)